-
1
-
-
0345601083
-
Met, metastasis, motility and more
-
C. Birchmeier, W. Birchmeier, E. Gherardi, and G. F. Vande Woude. Met, metastasis, motility and more. Nat. Rev., Mol. Cell Biol. 4:915-925 (2003).
-
(2003)
Nat. Rev., Mol. Cell Biol.
, vol.4
, pp. 915-925
-
-
Birchmeier, C.1
Birchmeier, W.2
Gherardi, E.3
Vande Woude, G.F.4
-
2
-
-
0036551486
-
Scatter-factor and semaphorin receptors: Cell signalling for invasive growth
-
L. Trusolino, and P. M. Comoglio. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev., Cancer. 2:289-300 (2002).
-
(2002)
Nat. Rev., Cancer
, vol.2
, pp. 289-300
-
-
Trusolino, L.1
Comoglio, P.M.2
-
3
-
-
0036221263
-
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
-
A. Danilkovitch-Miagkova, and B. Zbar. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest. 109:863-867 (2002).
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 863-867
-
-
Danilkovitch-Miagkova, A.1
Zbar, B.2
-
4
-
-
0036006814
-
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
-
G. Maulik, A. Shrikhande, T. Kijima, P. C. Ma, P. T. Morrison, and R. Salgia. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13:41-59 (2002).
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 41-59
-
-
Maulik, G.1
Shrikhande, A.2
Kijima, T.3
Ma, P.C.4
Morrison, P.T.5
Salgia, R.6
-
5
-
-
17344381429
-
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
-
L. Schmidt, F. M. Duh, F. Chen, T. Kishida, G. Glenn, P. Choyke, S. W. Scherer, Z. Zhuang, I. Lubensky, M. Dean, R. Allikmets, A. Chidambaram, U. R. Bergerheim, J. T. Feltis, C. Casadevall, A. Zamarron, M. Bernues, S. Richard, C. J. Lips, M. M. Walther, L. C. Tsui, L. Geil, M. L. Orcutt, T. Stackhouse, J. Lipan, L. Slife, H. Brauch, J. Decker, G. Niehans, M. D. Hughson, H. Moch, S. Storkel, M. I. Lerman, W. M. Linehan, and B. Zbar. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:68-73 (1997).
-
(1997)
Nat. Genet.
, vol.16
, pp. 68-73
-
-
Schmidt, L.1
Duh, F.M.2
Chen, F.3
Kishida, T.4
Glenn, G.5
Choyke, P.6
Scherer, S.W.7
Zhuang, Z.8
Lubensky, I.9
Dean, M.10
Allikmets, R.11
Chidambaram, A.12
Bergerheim, U.R.13
Feltis, J.T.14
Casadevall, C.15
Zamarron, A.16
Bernues, M.17
Richard, S.18
Lips, C.J.19
Walther, M.M.20
Tsui, L.C.21
Geil, L.22
Orcutt, M.L.23
Stackhouse, T.24
Lipan, J.25
Slife, L.26
Brauch, H.27
Decker, J.28
Niehans, G.29
Hughson, M.D.30
Moch, H.31
Storkel, S.32
Lerman, M.I.33
Linehan, W.M.34
Zbar, B.35
more..
-
6
-
-
13944276728
-
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer
-
P. C. Ma, R. Jagadeeswaran, S. Jagadeesh, M. S. Tretiakova, V. Nallasura, E. A. Fox, M. Hansen, E. Schaefer, K. Naoki, A. Lader, W. Richards, D. Sugarbaker, A. N. Husain, J. G. Christensen, and R. Salgia. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res. 65:1479-1488 (2005).
-
(2005)
Cancer Res.
, vol.65
, pp. 1479-1488
-
-
Ma, P.C.1
Jagadeeswaran, R.2
Jagadeesh, S.3
Tretiakova, M.S.4
Nallasura, V.5
Fox, E.A.6
Hansen, M.7
Schaefer, E.8
Naoki, K.9
Lader, A.10
Richards, W.11
Sugarbaker, D.12
Husain, A.N.13
Christensen, J.G.14
Salgia, R.15
-
7
-
-
28144442013
-
Inhibition of the met receptor in mesothelioma
-
T. Mukohara, G. Civiello, I. J. Davis, M. L. Taffaro, J. Christensen, D. E. Fisher, B. E. Johnson, and P. A. Janne. Inhibition of the met receptor in mesothelioma. Clin. Cancer Res. 11:8122-8130 (2005).
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 8122-8130
-
-
Mukohara, T.1
Civiello, G.2
Davis, I.J.3
Taffaro, M.L.4
Christensen, J.5
Fisher, D.E.6
Johnson, B.E.7
Janne, P.A.8
-
8
-
-
33644822482
-
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma
-
D. Forbs, S. Thiel, M. C. Stella, A. Sturzebecher, A. Schweinitz, T. Steinmetzer, J. Sturzebecher, and K. Uhland. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma. Int. J. Oncol. 27:1061-1070 (2005).
-
(2005)
Int. J. Oncol.
, vol.27
, pp. 1061-1070
-
-
Forbs, D.1
Thiel, S.2
Stella, M.C.3
Sturzebecher, A.4
Schweinitz, A.5
Steinmetzer, T.6
Sturzebecher, J.7
Uhland, K.8
-
9
-
-
32944467848
-
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c- Met-dependent human tumors
-
T. Burgess, A. Coxon, S. Meyer, J. Sun, K. Rex, T. Tsuruda, Q. Chen, S. Y. Ho, L. Li, S. Kaufman, K. McDorman, R. C. Cattley, J. Sun, G. Elliott, K. Zhang, X. Feng, X. C. Jia, L. Green, R. Radinsky, and R. Kendall. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c- Met-dependent human tumors. Cancer Res. 66:1721-1729 (2006).
-
(2006)
Cancer Res.
, vol.66
, pp. 1721-1729
-
-
Burgess, T.1
Coxon, A.2
Meyer, S.3
Sun, J.4
Rex, K.5
Tsuruda, T.6
Chen, Q.7
Ho, S.Y.8
Li, L.9
Kaufman, S.10
McDorman, K.11
Cattley, R.C.12
Sun, J.13
Elliott, G.14
Zhang, K.15
Feng, X.16
Jia, X.C.17
Green, L.18
Radinsky, R.19
Kendall, R.20
more..
-
12
-
-
0027275566
-
Physiological parameters in laboratory animals and humans
-
B. Davies, and T. Morris. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093-1095 (1993).
-
(1993)
Pharm. Res.
, vol.10
, pp. 1093-1095
-
-
Davies, B.1
Morris, T.2
-
13
-
-
8644234910
-
Antibody pharmacokinetics and pharmacodynamics
-
E. D. Lobo, R. J. Hansen, and J. P. Balthasar. Antibody pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 93:2645-2668 (2004).
-
(2004)
J. Pharm. Sci.
, vol.93
, pp. 2645-2668
-
-
Lobo, E.D.1
Hansen, R.J.2
Balthasar, J.P.3
-
14
-
-
10644289454
-
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
-
W. G. Jiang, T. A. Martin, C. Parr, G. Davies, K. Matsumoto, and T. Nakamura. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit. Rev. Oncol./Hematol. 53:35-69 (2005).
-
(2005)
Crit. Rev. Oncol./Hematol.
, vol.53
, pp. 35-69
-
-
Jiang, W.G.1
Martin, T.A.2
Parr, C.3
Davies, G.4
Matsumoto, K.5
Nakamura, T.6
-
15
-
-
0031304272
-
, et al. Met-HGF/SF tumorigenesis, invasion and metastatis
-
G. F. Vande Woude, M. Jeffers, J. Cortner, G. Alvord, I. Tsarfaty, and J. Resau. Met-HGF/SF: tumorigenesis, invasion and metastatis. Ciba Found Symp. 212:119-130 discussion 130-132, 148-154 (1997).
-
(1997)
Ciba Found Symp.
, vol.212
, pp. 119-130
-
-
Vande Woude, G.F.1
Jeffers, M.2
Cortner, J.3
Cortner, J.4
Alvord, G.5
Tsarfaty, I.6
Resau, J.7
-
16
-
-
34548579388
-
Characterization of fully human monoclonal antibodies to human hepatocyte growth factor
-
presented as a Washington, DC
-
T. Burgess, J. Sun, S. Meyer, J. Sun, G. Elliott, Q. Chen, S.Y. Ho, R. Jacobsen, H. Kim, R. Deshpande, F. Martin, T. Tsuruda, K. Zhang, M. Haniu, A. Coxon, and R. Kendall. Characterization of fully human monoclonal antibodies to human hepatocyte growth factor, presented as a "Late Breaking" Abstract #288 at the AACR Annual Meeting, Washington, DC, 2006.
-
(2006)
"Late Breaking" Abstract #288 at the AACR Annual Meeting
-
-
Burgess, T.1
Sun, J.2
Meyer, S.3
Sun, J.4
Elliott, G.5
Chen, Q.6
Ho, S.Y.7
Jacobsen, R.8
Kim, H.9
Deshpande, R.10
Martin, F.11
Tsuruda, T.12
Zhang, K.13
Haniu, M.14
Coxon, A.15
Kendall, R.16
|